We’ve been using Hyperstacks with optimized gas exchange for production but we need to scale up. We want to maintain the same gas exchange capabilities.
This question is part of the following Ask The Expert session:
Answered by:
Company: MilliporeSigma
Job Title: Head of Technical Operations, Viral and Gene Therapy Manufacturing
Answer
For adherent processes that need to be scaled up beyond HYPERStack/CellSTACK scale, we have used an iCELLis® bioreactor. This system utilizes single use fixed bed bioreactors with up to 500 m2 of growth area, the equivalent of nearly 800 CellSTACKs. The system has been designed to enable optimal gas exchange, but it would take some work to ensure that you have a process that can match or exceed your current productivity/volume. They do offer an iCELLis Nano system for smaller scale feasibility work (up to 4 m2 of growth area). There are also other vendors who have or are developing fixed bed bioreactors for use when adherent processes need to be scaled up beyond the HYPERStack/CellSTACK scale when moving to suspension is not feasible.
This post is sponsored by MilliporeSigma.